Welcome to MedArena!

Your trusted destination for CME, CPD & Medical Education across the Middle East.

Information

  • Address:MedArena Corporation
  • Call Us:1 (800) 828-2059
  • Email:support [at] medarenaevents.com
Shannon Cheung

Achievements

—Co-founded Likang Life Sciences.
—Serves as Vice Chairman of Likang Life Sciences.
—Works in the development of personalized cancer vaccines and cell therapies.

Shannon Cheung

Co-Founder & Vice Chairman

Likang Life Sciences

About

Shannon Cheung is a biotechnology and life-sciences entrepreneur and executive serving as Co-Founder and Vice Chairman of Likang Life Sciences. His work focuses on the development of innovative technologies in areas including personalized cancer treatment, genomics, neoantigen discovery and advanced immunotherapy. He has described Likang's work as centered on personalized cancer vaccines and cell therapies. His participation at the Summit represents the biotechnology and precision-oncology dimension of the Future Health program, particularly its focus on translating advances in genomics and molecular biology into individualized therapies.

Shannon Cheung, also known as Cheung Wing Hong Shannon, is a Hong Kong-based entrepreneur, investor, and venture builder with more than 20 years of experience in investment, corporate finance, banking, and business development. He is the founder and chairman of Averest Capital Group, through which he supports emerging businesses, provides strategic guidance, and helps companies secure financing and expand into new markets.

Throughout his career, Cheung has developed experience across multiple industries, including biotechnology, life sciences, healthcare technology, financial technology, esports, digital media, and internet services. His work combines investment expertise with a focus on building innovative companies and supporting entrepreneurs as they develop and commercialize new technologies.

One of his significant areas of involvement is biotechnology and precision medicine through Likang Life Sciences, where he serves as co-founder and vice chairman. The company focuses on advanced cancer-treatment technologies, including personalized neoantigen messenger RNA (mRNA) cancer vaccines and cell therapies. These approaches aim to develop treatments tailored to the biological characteristics of individual patients and their tumors.

Likang Life Sciences has attracted attention for its work on personalized cancer vaccines. Its neoantigen mRNA vaccine program achieved an important regulatory milestone in China in March 2023, when it received authorization to enter clinical trials from the National Medical Products Administration. In February 2025, the company also received U.S. Food and Drug Administration clearance for an Investigational New Drug application, according to publicly available professional biographies.

Beyond biotechnology, Cheung has co-founded and supported businesses in gaming, esports, sports media, and financial technology. His entrepreneurial portfolio includes Hero Games, Hero Esports, All Football, and DIB Group. Through these ventures, he has contributed to the development and growth of businesses operating in rapidly evolving technology-driven industries.

Before establishing Averest Capital Group, Cheung held senior positions at HSBC, including Managing Director of Global Banking and Chief Representative of the bank's Securities Business Beijing Representative Office. His responsibilities included originating business opportunities in mainland China, advising on initial public offerings, facilitating equity-related transactions, supporting mergers and acquisitions, and working on high-yield bond issuance.

Cheung has also been recognized for his public and community service in Hong Kong. He was awarded the Medal of Honour in 2014 and appointed a Justice of the Peace in 2019.

His professional background brings together financial services, entrepreneurship, strategic investment, and biotechnology development. His involvement with Likang Life Sciences is particularly relevant to the advancement of precision oncology, personalized cancer vaccines, and emerging therapeutic technologies.

Full Achievement Timeline

Before 2014 — Development of a Career in Investment and Banking

  • Built professional experience in investment, corporate finance, banking, and business development.
  • Developed expertise in capital markets, investment strategy, fundraising, and corporate transactions.
  • Established a foundation for later work in entrepreneurship and venture building.

2014 — Awarded the Hong Kong Medal of Honour

  • Received the Medal of Honour (MH) from the Hong Kong government in recognition of contributions to public and community service.
  • This recognition forms part of his record of public service alongside his corporate career.

Before Founding Averest Capital Group — Senior Leadership at HSBC

  • Served as Managing Director of Global Banking and Chief Representative of HSBC's Securities Business Beijing Representative Office.
  • Led business origination activities in mainland China.
  • Worked on initial public offerings, equity-related transactions, mergers and acquisitions advisory, and high-yield bond issuance.
  • Developed experience in cross-border business, financial advisory, and corporate financing.

2010s–2020s — Founder and Chairman of Averest Capital Group

  • Founded Averest Capital Group and established his position as an investor and venture builder.
  • Built a portfolio spanning technology, biotechnology, healthcare, financial technology, gaming, and digital media.
  • Supported entrepreneurs through strategic advice, investment expertise, international business connections, and fundraising assistance.
  • Developed a professional track record spanning more than 20 years in investment and venture building.

2010s–2020s — Co-Founder of Hero Games

  • Co-founded Hero Games, a gaming company involved in developing and supporting game studios.
  • Contributed to the growth of businesses in the interactive entertainment and digital gaming industries.
  • The company's wider ecosystem includes studios associated with titles such as Black Myth: Wukong and Wuthering Waves.

2010s–2020s — Co-Founder of All Football

  • Co-founded All Football, a digital football media platform.
  • Supported the development of a technology-based platform providing football news, match information, and statistics.

2010s–2020s — Co-Founder of DIB Group

  • Co-founded DIB Group, a financial technology and asset management business.
  • Supported the development of investment services incorporating big data and artificial intelligence technologies.

2019 — Appointed Justice of the Peace

  • Was appointed a Justice of the Peace (JP) by the Hong Kong government.
  • The appointment added to his public-service recognition and professional standing.

March 2023 — Major Milestone in Personalized Cancer Vaccine Development

  • Through his involvement as co-founder and vice chairman of Likang Life Sciences, was associated with the company's progress in personalized neoantigen mRNA cancer vaccine development.
  • The company's vaccine program received authorization from China's National Medical Products Administration to enter clinical trials.
  • This milestone represented an important step toward evaluating personalized cancer vaccine technology in clinical research.

2023 — Supported a Major Investment in Hero Esports

  • Advised and assisted VSPO, now known as Hero Esports, in securing a landmark investment of approximately US$265 million from Savvy Games Group, which is backed by Saudi Arabia's Public Investment Fund.
  • This transaction represented a significant financing milestone for the esports business and its development.

February 2025 — U.S. Regulatory Milestone for Likang Life Sciences

  • Likang Life Sciences received U.S. Food and Drug Administration clearance for an Investigational New Drug application related to its personalized cancer vaccine program, as reported in professional biographies.
  • This development marked progress toward advancing the company's research into the U.S. clinical development pathway.
  • The regulatory milestone should not be interpreted as FDA approval to market the vaccine or proof of clinical efficacy.

March 2025 — Participation in the Milken Institute Global Investors' Symposium

  • Featured as a speaker at the Milken Institute's Global Investors' Symposium in Hong Kong.
  • Participated in the Global Investors' View: China panel.
  • Contributed an investment-sector perspective on China's economic outlook, capital markets, and investment opportunities.

March 2026 — Continued Leadership in Investment and Venture Building

  • Listed as Chairman and CEO of Averest Capital at the Milken Institute Global Investors' Symposium in Hong Kong.
  • Continued to be recognized for his experience in investment, entrepreneurship, technology, and biotechnology.
  • His professional portfolio continued to span established ventures and emerging technology businesses.

Major Achievements and Recognitions

1. Medal of Honour, Hong Kong — 2014

Recognized by the Hong Kong government for public and community service.

2. Justice of the Peace, Hong Kong — 2019

Appointed in recognition of his public-service contributions.

3. Founder and Chairman of Averest Capital Group

Established an investment and venture-building platform supporting businesses across multiple industries.

4. Co-Founder and Vice Chairman of Likang Life Sciences

Contributed to the leadership of a biotechnology company developing personalized cancer vaccines and advanced therapeutic technologies.

5. Contribution to Personalized Cancer Vaccine Development

Associated with the development of a neoantigen mRNA cancer vaccine program that achieved important regulatory milestones in China in 2023 and the United States in 2025.

6. Contribution to Technology and Gaming Entrepreneurship

Co-founded businesses spanning gaming, esports, football media, and financial technology.

7. Involvement in a Major Esports Investment Transaction

Helped advise and support VSPO in securing an approximately US$265 million investment from Savvy Games Group in 2023.

8. International Investment Industry Recognition

Participated as a speaker at the Milken Institute's Global Investors' Symposium in Hong Kong in 2025 and 2026.

Institutional Affiliations

Averest Capital Group

Position: Founder and Chairman; also identified as Chairman and CEO in professional speaker biographies.

Focus: Investment, venture building, corporate strategy, and business development.

Likang Life Sciences

Position: Co-Founder and Vice Chairman.

Focus: Biotechnology, personalized cancer vaccines, neoantigen research, and advanced cancer therapies.

Hero Games

Position: Co-Founder.

Focus: Video game development and gaming industry investment.

Hero Esports (formerly VSPO)

Professional involvement: Co-founder and investor; advised and assisted the company in a major investment transaction in 2023.

Focus: Esports and competitive gaming.

All Football

Position: Co-Founder.

Focus: Digital football media and sports information technology.

DIB Group

Position: Co-Founder.

Focus: Financial technology, asset management, big data, and artificial intelligence.

Professional Summary

Shannon Cheung is an entrepreneur, investor, and venture builder with more than two decades of experience in investment, banking, corporate finance, and technology-driven businesses. As founder and chairman of Averest Capital Group and co-founder and vice chairman of Likang Life Sciences, he has developed a portfolio spanning financial services, biotechnology, gaming, esports, digital media, and financial technology.

His career combines senior financial-sector leadership with entrepreneurship and strategic investment. His involvement in personalized cancer vaccine development is particularly relevant to the biotechnology and precision-oncology sectors, while his public-service recognition includes the Hong Kong Medal of Honour in 2014 and appointment as a Justice of the Peace in 2019.

Events & Activities

Abu Dhabi Future Health Summit 2026
Oct 20, 2026
In-Person

Abu Dhabi Future Health Summit 2026

dmg events

  • CME Credits
  • Abu Dhabi National Exhibition Centre (ADNEC), Abu Dhabi
Oct 20, 2026
In-Person

Abu Dhabi Future Health Summit 2026

Free

The Abu Dhabi Future Health Summit 2026 is a premier global platform uniting researchers, policymakers, and healthcare specialists to drive transformative health innovation and accelerate collaboration for longer, healthier lives.

dmg events

  • 3 Days
  • Abu Dhabi National Exhibition Centre (ADNEC), Abu Dhabi
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
CME Certified Courses
Medical Education Hub
Expert Medical Speakers
AI-Powered Learning
Accredited Certificates
Live Medical Events
Continuous Medical Education
Shannon Cheung — Co-Founder & Vice Chairman | MedArena